Bei Q. Mao

No. 12 Wulumuqi Middle Road
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Type IIB PKA serves as the primary effector of Gs-coupled receptor-potentiated insulin secretion in mice by orchestrating ion channels and granule phenotype.

Type IIB PKA serves as the primary effector of Gs-coupled receptor-potentiated insulin secretion in mice by orchestrating ion channels and granule phenotype.

Journal: Diabetologia

Published: January 23, 2026

Nasal nitric oxide combined with clinical features for preliminary screening of primary ciliary dyskinesia in bronchiectasis.

Nasal nitric oxide combined with clinical features for preliminary screening of primary ciliary dyskinesia in bronchiectasis.

Journal: The European respiratory journal

Published: December 31, 2025

Evidence for Interleukin-17C governing interleukin-17A pathogenicity and promoting asthma endotype switching in bronchiectasis.

Evidence for Interleukin-17C governing interleukin-17A pathogenicity and promoting asthma endotype switching in bronchiectasis.

Journal: Nature communications

Published: September 23, 2024

Germline AIP variants in sporadic young acromegaly and pituitary gigantism: clinical and genetic insights from a Han Chinese cohort.

Germline AIP variants in sporadic young acromegaly and pituitary gigantism: clinical and genetic insights from a Han Chinese cohort.

Journal: Endocrine

Published: February 29, 2024

Fractional exhaled nitric oxide, a potential biomarker for evaluating glucocorticoids treatment and prognosis in allergic bronchopulmonary aspergillosis.

Fractional exhaled nitric oxide, a potential biomarker for evaluating glucocorticoids treatment and prognosis in allergic bronchopulmonary aspergillosis.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: February 20, 2024

A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for Pseudomonas aeruginosa eradication in bronchiectasis: ERASE.

A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for Pseudomonas aeruginosa eradication in bronchiectasis: ERASE.

Journal: ERJ open research

Published: December 04, 2023

The role of volatile organic compounds for assessing characteristics and severity of non-cystic fibrosis bronchiectasis: an observational study.

The role of volatile organic compounds for assessing characteristics and severity of non-cystic fibrosis bronchiectasis: an observational study.

Journal: Frontiers in medicine

Published: November 27, 2023

Quality-of-Life Bronchiectasis Respiratory Symptom Scale Predicts the Risk of Exacerbations in Adults with Bronchiectasis: A Prospective Observational Study.

Quality-of-Life Bronchiectasis Respiratory Symptom Scale Predicts the Risk of Exacerbations in Adults with Bronchiectasis: A Prospective Observational Study.

Journal: Annals of the American Thoracic Society

Published: November 14, 2023

Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study.

Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study.

Journal: Respiratory research

Published: February 06, 2023

Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis.

Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis.

Journal: Respiratory research

Published: August 11, 2022

The impact of depression and anxiety on the risk of exacerbation in adults with bronchiectasis: a prospective cohort study.

The impact of depression and anxiety on the risk of exacerbation in adults with bronchiectasis: a prospective cohort study.

Journal: The European respiratory journal

Published: July 14, 2022

ROS attenuates TET2-dependent ZO-1 epigenetic expression in cerebral vascular endothelial cells.

ROS attenuates TET2-dependent ZO-1 epigenetic expression in cerebral vascular endothelial cells.

Journal: Fluids and barriers of the CNS

Published: June 28, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026